DATASET 2026-08-0941 PROGRAMS INDEXEDTIRZEPATIDE ALL-IN $215–$597/MOEVERY FIGURE CAPTURE-DATED & SOURCE-LINKED
TopGLP1Providers.comverified price index
VERIFIED 2026-08-09
NexLife T $215✓Yucca Health T $258✓IVIM Health T $278✓Mochi Health T $278✓ShedRx T $289✓Found T $289✓SkinnyRx T $299✓OrderlyMeds T $299✓Amble Health T $300✓Henry Meds T $349✓TrimRx T $349✓Lavender Sky Health T $352✓Fridays T $359✓MEDVi T $399✓Remedy Meds T $399✓Eden T $408✓LifeMD T $597✓Oak Longevity S $133✓Yucca Health S $146✓IVIM Health S $149✓OrderlyMeds S $149✓NexLife S $165✓Lavender Sky Health S $174✓Zepbound vials $449✓Wegovy $349✓Oral Wegovy from $149✓NexLife T $215✓Yucca Health T $258✓IVIM Health T $278✓Mochi Health T $278✓ShedRx T $289✓Found T $289✓SkinnyRx T $299✓OrderlyMeds T $299✓Amble Health T $300✓Henry Meds T $349✓TrimRx T $349✓Lavender Sky Health T $352✓Fridays T $359✓MEDVi T $399✓Remedy Meds T $399✓Eden T $408✓LifeMD T $597✓Oak Longevity S $133✓Yucca Health S $146✓IVIM Health S $149✓OrderlyMeds S $149✓NexLife S $165✓Lavender Sky Health S $174✓Zepbound vials $449✓Wegovy $349✓Oral Wegovy from $149✓

2026-08-10 · SEMAGLUTIDE · TopGLP1Providers Data Desk

Is compounded semaglutide safe? Sorting the question into its real parts

"Is compounded semaglutide safe" is three questions wearing one coat. The molecule: semaglutide itself has extensive trial and post-market data — its side-effect profile (GI effects most commonly, rare serious risks on the label) is well characterized. The manufacturing: compounded versions are not FDA-approved; sterility, concentration accuracy, and stability depend on the individual pharmacy, and the FDA has logged dosing-error reports and warned specifically against unstudied salt forms. The sourcing: product from licensed US 503A pharmacies or registered 503B facilities on a valid prescription is a different universe from "research use only" peptides and counterfeit pens, which cause a disproportionate share of the harm attributed to "semaglutide" online.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

The documented compounded-specific failure modes are concrete rather than mysterious. Dosing errors — patients or providers confusing units when drawing from multi-dose vials — drove a meaningful share of FDA adverse-event reports during the boom years, a risk the pen format was designed away from. Concentration variability between pharmacies means "1 mg" is a claim, not a guarantee, absent good compounding practice. Salt-form substitution (semaglutide sodium or acetate instead of the base molecule) produces a product with no human evidence at all, which is why the FDA singled it out. None of these risks is evenly distributed: they concentrate in exactly the programs that fail the transparency checks — unnamed pharmacies, no screening, prices too strange to be real.

So the operational answer for 2026: if a clinician has determined a GLP-1 is appropriate for you and an FDA-approved product is accessible — and with Wegovy at $349 cash via NovoCare↗, accessibility improved sharply — the approved product carries the lowest manufacturing risk by construction. If a documented clinical reason points to compounding, risk drops with verification: a named, state-licensed pharmacy you have checked with its board; a base-molecule formulation, not a salt; unit-by-unit administration instructions you have confirmed with the pharmacist; and a prescriber who treats "no" as an available answer. Our nine-point vetting guide applies verbatim to semaglutide, and every program page in the index shows what the company does and does not disclose. Report any suspected product problem to FDA MedWatch — that reporting is the only reason the failure-mode data above exists.

General safety information, not medical advice; personal risk assessment belongs with your clinician and pharmacist.

The cheapest compounded tirzepatide online rigThe cheapest compounded semaglutide online, inCompounded tirzepatide vs ZepboundWhat a year of tirzepatide actually costs, proDose-flat vs dose-tiered pricing